Detalles de la búsqueda
1.
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Lancet
; 403(10426): 533-544, 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310910
2.
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
Lancet
; 397(10287): 1809-1818, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33964223
3.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Lancet
; 397(10269): 99-111, 2021 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33306989
4.
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Lancet
; 396(10267): 1979-1993, 2021 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33220855
5.
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
J Infect Dis
; 219(8): 1187-1197, 2019 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407513
6.
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
PLoS Med
; 16(4): e1002790, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31039172
7.
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.
Mol Ther
; 25(2): 547-559, 2017 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28153101
8.
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.
Mol Ther
; 24(8): 1470-7, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27109630
9.
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
J Infect Dis
; 213(11): 1743-51, 2016 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26908756
10.
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.
J Infect Dis
; 214(5): 772-81, 2016 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27307573
11.
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
J Infect Dis
; 211(7): 1076-86, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25336730
12.
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
Mol Ther
; 22(12): 2142-2154, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25156127
13.
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
Mol Ther
; 22(11): 1992-2003, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24930599
14.
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial.
Lancet Infect Dis
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621405
15.
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
Mol Ther
; 20(12): 2355-68, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23089736
16.
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.
Am J Respir Crit Care Med
; 185(7): 769-78, 2012 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22281831
17.
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
J Infect Dis
; 205(5): 772-81, 2012 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22275401
18.
Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial.
Lancet Infect Dis
; 23(8): 956-964, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060917
19.
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.
Med
; 4(10): 668-686.e7, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37572659
20.
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Sci Transl Med
; 15(704): eadf1782, 2023 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437014